OncoCyte EchelonDx, Oncocyte to Develop Software Supporting Commercial Diagnostics Expansion The two firms are developing an analytical software solution to help Oncocyte scale its commercial oncology test business to a global scale. Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock The company said any proceeds raised will help continue commercialization of its lead test, DetermaRx, and fund the development of the rest of its pipeline. Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients. Oncocyte Posts $1.1M in Q1 Revenues, Beating Wall Street Expectations The firm's first quarter revenue growth was driven by sales of its DetermaRx lung cancer recurrence risk test and growth in its pharma services business. Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor The firm presented evidence that its DetermaIO gene expression test can help predict which bladder cancer patients are likely to respond to immune checkpoint inhibitors. Mar 18, 2021 Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests Premium Mar 16, 2021 Oncocyte Posts $503K in Q4 Revenues, Misses Wall Street Expectations Mar 12, 2021 People in the News: New Appointments at Oncocyte, Ontera, Agilent, More Feb 25, 2021 Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition Feb 5, 2021 Oncocyte to Raise $35M in Public Stock Offering Feb 2, 2021 Oncocyte to Acquire Chronix Biomedical Jan 20, 2021 Oncocyte to Raise $25M in Stock Sale to Institutional Investors Dec 16, 2020 Piper Sandler Raises Rating on Oncocyte to Overweight Dec 15, 2020 Burning Rock Biotech Licenses Oncocyte Lung Cancer Assay Nov 30, 2020 BTIG Initiates Coverage of Oncocyte With Buy Rating Nov 12, 2020 OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises Oct 21, 2020 Oncocyte DetermaRx Predicts Early Lung Cancer Outcomes Regardless of EGFR Status Premium Oct 8, 2020 Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction Oct 2, 2020 In Brief This Week: Illumina, BGI, Thermo Fisher, Genetron, Yourgene, Caris Life Sciences, More Oct 1, 2020 Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology Sep 3, 2020 Oncocyte, Guardian Research Network Partner to Improve Precision Medicine Clinical Trials Jul 30, 2020 Oncocyte Provides Post-Mortem on DetermaDx Failure, Describes Renewed Focus on Remaining Assays Premium Jul 29, 2020 OncoCyte Q2 Net Loss Ticks Up Jul 16, 2020 ProGenetics to Distribute Oncocyte Lung Cancer Test in Israel Jul 15, 2020 Noridian Providing Limited Coverage for MDx Tests as Predictive Classifiers for NSCLC Load More Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.